Rishub K. Das, BA1; Oren Ganor, MD, MSc2; Brian C. Drolet, MD3
doi : 10.1001/jamapediatrics.2022.6157
April 2023, Vol 177, No. 4, Pages 327-441
Paul A. Offit, MD1
Lauren Fiechtner, MD, MPH1,2; Jennifer Woo Baidal, MD, MPH3; Erika R. Cheng, PhD, MPA4
Jane Tuckerman, PhD1,2,3; Kelly Harper, BHSc4,5; Thomas R. Sullivan, PhD6,7; Alana R. Cuthbert, PhD6; Jennifer Fereday, PhD4; Jennifer Couper, MD1,4,5; Nicholas Smith, PhD1,4; Andrew Tai, PhD1,4,5; Andrew Kelly, MBBS1,4; Richard Couper, MBChB4; Mark Friswell, MBChB4; Louise Flood, MBBS8; Christopher C. Blyth, PhD9,10,11,12; Margie Danchin, PhD2,3,13; Helen S. Marshall, MD1,4,5
doi : 10.1001/jamapediatrics.2022.6145
Importance Children with chronic medical conditions are at increased risk of severe influenza. Uptake of influenza vaccination in children and adolescents with these identified special risk medical conditions (SRMCs) is suboptimal.
Marta Latek, MSc1; Piotr �acwik, MD, PhD2; Katarzyna Molińska, MSc1; Andrzej Błauż, MSc, PhD3; Jakub Lach, MSc4; Błażej Rychlik, MSc, PhD3; Dominik Strapagiel, MSc, PhD4; Joanna Majak, MD, PhD5; Joanna Molińska, MSc1; Dorota Czech, MD, PhD6; Michał Seweryn, PhD7; Piotr Kuna, MD, PhD1; Cezary Pałczyński, MD, PhD2; Paweł Majak, MD, PhD8
doi : 10.1001/jamapediatrics.2022.6172
Importance Intranasal corticosteroids (INCs) remain the first-line treatment of chronic rhinosinusitis (CRS) in both adults and children, despite the lack of evidence regarding their efficacy in the pediatric population. Similarly, their effect on the sinonasal microbiome has not been well documented.
Nathalie Gharibeh, PhD1; Maryam Razaghi, PhD1; Catherine A. Vanstone, RN, MSc1; Olusola F. Sotunde, PhD1; Laura Glenn, RD, MSc1; Kristina Mullahoo, RD, MSc1; Zahra Farahnak, PhD1,2; Ali Khamessan, PhD3; Shu Qin Wei, MD, PhD4; Dayre McNally, MD, PhD5; Frank Rauch, MD6; Glenville Jones, PhD7; Martin Kaufmann, PhD7; Hope A. Weiler, PhD1,8
doi : 10.1001/jamapediatrics.2022.5837
Importance The dose of supplemental vitamin D needed in infants born with serum 25-hydroxyvitamin D (25[OH]D) concentrations less than 50 nmol/L (ie, 20 ng/mL) is unclear.
José Francisco López-Gil, PhD1,2; Antonio GarcÃa-Hermoso, PhD3; Lee Smith, PhD4; Joseph Firth, PhD5,6; Mike Trott, PhD4,7; Arthur Eumann Mesas, PhD1,8; Estela Jiménez-López, PhD1; Héctor Gutiérrez-Espinoza, PhD9; Pedro J. Tárraga-López, PhD10; Desirée Victoria-Montesinos, PhD11
doi : 10.1001/jamapediatrics.2022.5848
Importance The 5-item Sick, Control, One, Fat, Food (SCOFF) questionnaire is the most widely used screening measure for eating disorders. However, no previous systematic review and meta-analysis determined the proportion of disordered eating among children and adolescents.
Andrea Trubanova Wieckowski, PhD1; Lashae N. Williams, MS1; Juliette Rando, MPH1; Kristen Lyall, ScD1; Diana L. Robins, PhD1
doi : 10.1001/jamapediatrics.2022.5975
Importance The Modified Checklist for Autism in Toddlers (M-CHAT) and the M-CHAT, Revised With Follow-up (M-CHAT-R/F)—henceforth referred to as M-CHAT(-R/F)—are the most commonly used toddler screeners for autism spectrum disorder (ASD). Their use often differs from that in the original validation studies, resulting in a range of estimates of sensitivity and specificity.
Atsuyuki Watanabe, MD1; Ryoma Kani2; Masao Iwagami, MD, PhD3,4; Hisato Takagi, MD, PhD5; Jun Yasuhara, MD6; Toshiki Kuno, MD, PhD7
doi : 10.1001/jamapediatrics.2022.6243
Importance Evidence of the efficacy and safety of messenger RNA (mRNA) COVID-19 vaccines in children aged 5 to 11 years has been emerging. Collecting these data will inform clinicians, families, and policy makers.
Tami H. Skoff, MS1; Li Deng, PhD1; Catherine H. Bozio, PhD1,2; Susan Hariri, PhD1
doi : 10.1001/jamapediatrics.2022.5689
Importance Infants younger than 1 year have the highest burden of pertussis morbidity and mortality. In 2011, the US introduced tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination during pregnancy to protect infants before vaccinations begin.
Aruna Chandran, MD, MPH1; Mohamad Burjak, MS1; Joshua Petimar, ScD2; Ghassan Hamra, PhD1; Melissa M. Melough, PhD3; Anne L. Dunlop, MD, MPH4; Brittney M. Snyder, PhD5; Augusto A. Litonjua, MD, MPH6; Tina Hartert, MD, MPH7; James Gern, MD8,9; Akram N. Alshawabkeh, PhD10; Judy Aschner, MD11,12; Carlos A. Camargo Jr, MD, DrPH13; Dana Dabelea, MD, PhD14; Cristiane S. Duarte, PhD, MPH15; Assiamira Ferrara, MD, PhD16; Jody M. Ganiban, PhD17; Frank Gilliland, MD, PhD18; Diane R. Gold, MD, MPH19,20; Monique Hedderson, PhD, MPH16; Julie B. Herbstman, PhD21; Christine Hockett, PhD22,23; Margaret R. Karagas, PhD24; Jean M. Kerver, PhD25,26; Kathleen A. Lee-Sarwar, MD19,27; Barry Lester, PhD28; Cindy T. McEvoy, MD29; Zhongzheng Niu, PhD18; Joseph B. Stanford, MD30,31; Rosalind Wright, MD, MPH32; Emily Zimmerman, PhD33; Shohreh Farzan, PhD19; Zhumin Zhang, PhD34; Emily Knapp, PhD1
doi : 10.1001/jamapediatrics.2022.5828
Importance The prevalence of obesity among youths 2 to 19 years of age in the US from 2017 to 2018 was 19.3%; previous studies suggested that school lunch consumption was associated with increased obesity. The Healthy, Hunger-Free Kids Act of 2010 (HHFKA) strengthened nutritional standards of school-based meals.
Sarah A. Buchan, PhD1,2,3; Sarah Alley, MPH1; Chi Yon Seo, MSc1; Caitlin Johnson, MPH1; Jeffrey C. Kwong, MD1,2,3,4,5; Sharifa Nasreen, PhD2,3; Nisha Thampi, MD1,6; Diane Lu, MD1; Tara M. Harris, MHSc1; Andrew Calzavara, MSc2; Sarah E. Wilson, MD1,2,3
doi : 10.1001/jamapediatrics.2022.6166
Importance The risk of myocarditis or pericarditis after COVID-19 messenger RNA vaccines varies by age and sex, and there is some evidence to suggest increasing risk with shorter intervals between dose 1 and 2 (ie, interdose interval).
Samantha Schlossarek, MSc1; Hannah Schmidt, MSc1,2; Anja Bischof, PhD1; Gallus Bischof, PhD1; Dominique Brandt, MSc1; Stefan Borgwardt, MD1; Dillon T. Browne, PhD3; Dimitri Christakis, MD, MPH4; Pamela Hurst-Della Pietra, DO5; Zsolt Demetrocvics, PhD6,7; Hans-Jürgen Rumpf, PhD1
doi : 10.1001/jamapediatrics.2022.5741
Importance Children and adolescents spend considerable time on the internet, which makes them a highly vulnerable group for the development of problematic usage patterns. A variety of screening methods have already been developed and validated for social network use disorder (SNUD); however, a systematic review of SNUD in younger age groups has not been performed.
Michelle Curtin, DO1; Lindsay A. Thompson, MD, MS1
Sarah C. J. Jorgensen, PharmD, MPH1; Alejandro Hernandez, MSc2; Deshayne B. Fell, PhD3; Peter C. Austin, PhD2; Rohan D’Souza, MD, PhD4; Astrid Guttmann, MDCM, MSc2; Jeffrey C. Kwong, MD, MSc2
Qingxiao Li, PhD1; Shuoli Zhao, PhD2; Metin Çakır, PhD3; Zhixiu Yu, PhD4
Kelsi Batioja, BS1; Covenant Elenwo, MPH1; Micah Hartwell, PhD2
Noura Insolera, PhD, MA1
Alex R. Kemper, MD, MPH, MS1; Thomas B. Newman, MD, MPH2,3; Joseph L. Wright, MD, MPH4,5
William Christopher Golden, MD1
Sharon Ostfeld-Johns, MD1; Elena Aragona, MD1; Louis Hart, MD1
Riccardo Davanzo, MD, PhD1
Jennifer M. Nelson, MD, MPH1; Katherine E. Fleming-Dutra, MD2; Dana Meaney-Delman, MD, MPH3
Nazeeh Hanna, MD1; Christie Clauss, PharmD2; Leonard R. Krilov, MD3
Miles M. Weinberger, MD1
Qinyuan Li, MD1,2,3,4; Yaolong Chen, MD, PhD5,6; Zhengxiu Luo, MD1,2,3,4
Do you want to add Medilib to your home screen?